Search

Your search keyword '"Wedel, Hans"' showing total 899 results
Start Over Author "Wedel, Hans"
899 results on '"Wedel, Hans"'

201. [Metabolic control by means of insulin in patients with type 2 diabetes and acute myocardial infarction (DIGAMI 2) : effects on mortality and morbidity--secondary publication]

Author

Gustafsson, Ida, Malmberg, Klas, Rydén, Lars, Wedel, Hans, Birkeland, Kåre, Bootsma, Aart, Dickstein, Kenneth, Efendic, Suad, Fisher, Miles, Hamsten, Anders, Herlitz, Johan, Hildebrandt, Per Rossen, MacLeod, Kenneth, Laakso, Markku, Torp-Pedersen, Christian T, Waldenström, Anders, Gustafsson, Ida, Malmberg, Klas, Rydén, Lars, Wedel, Hans, Birkeland, Kåre, Bootsma, Aart, Dickstein, Kenneth, Efendic, Suad, Fisher, Miles, Hamsten, Anders, Herlitz, Johan, Hildebrandt, Per Rossen, MacLeod, Kenneth, Laakso, Markku, Torp-Pedersen, Christian T, and Waldenström, Anders

Published
2006

203. The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin : the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.

Author

Fossum, Eigil, Moan, Andreas, Kjeldsen, Sverre E, Devereux, Richard B, Julius, Stevo, Snapinn, Steven M, Edelman, Jonathan M, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Dahlöf, Björn, Fossum, Eigil, Moan, Andreas, Kjeldsen, Sverre E, Devereux, Richard B, Julius, Stevo, Snapinn, Steven M, Edelman, Jonathan M, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, and Dahlöf, Björn

Published
2005
Full Text
View/download PDF

204. Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.

Author

Fyhrquist, Frej, Dahlöf, Björn, Devereux, Richard B, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Hille, Darcy A, Lyle, Paulette A, Edelman, Jonathan M, Snapinn, Steven M, Wedel, Hans, Fyhrquist, Frej, Dahlöf, Björn, Devereux, Richard B, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Hille, Darcy A, Lyle, Paulette A, Edelman, Jonathan M, Snapinn, Steven M, and Wedel, Hans

Published
2005
Full Text
View/download PDF

205. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.

Author

Kjeldsen, Sverre E, Lyle, Paulette A, Kizer, Jorge R, Dahlöf, Björn, Devereux, Richard B, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Snapinn, Steven M, Harris, Katherine E, Wedel, Hans, Kjeldsen, Sverre E, Lyle, Paulette A, Kizer, Jorge R, Dahlöf, Björn, Devereux, Richard B, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Snapinn, Steven M, Harris, Katherine E, and Wedel, Hans

Published
2005

206. Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension : angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Author

Kjeldsen, Sverre E, Lyle, Paulette A, Tershakovec, Andrew M, Devereux, Richard B, Oparil, Suzanne, Dahlöf, Björn, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Wedel, Hans, Kjeldsen, Sverre E, Lyle, Paulette A, Tershakovec, Andrew M, Devereux, Richard B, Oparil, Suzanne, Dahlöf, Björn, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, and Wedel, Hans

Published
2005
Full Text
View/download PDF

207. Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol : the Losartan Intervention For Endpoint reduction in hypertension study.

Author

Kizer, Jorge R, Dahlöf, Björn, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Wachtell, Kristian, Edelman, Jonathan M, Snapinn, Steven M, Harris, Katherine E, Devereux, Richard B, Kizer, Jorge R, Dahlöf, Björn, Kjeldsen, Sverre E, Julius, Stevo, Beevers, Gareth, de Faire, Ulf, Fyhrquist, Frej, Ibsen, Hans, Kristianson, Krister, Lederballe-Pedersen, Ole, Lindholm, Lars H, Nieminen, Markku S, Omvik, Per, Oparil, Suzanne, Wedel, Hans, Wachtell, Kristian, Edelman, Jonathan M, Snapinn, Steven M, Harris, Katherine E, and Devereux, Richard B

Published
2005
Full Text
View/download PDF

209. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)

Author

Sever, Peter S, Poulter, Neil R, Dahlöf, Björn, Wedel, Hans, Collins, Rory, Beevers, Gareth, Caulfield, Mark, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, Sever, Peter S, Poulter, Neil R, Dahlöf, Björn, Wedel, Hans, Collins, Rory, Beevers, Gareth, Caulfield, Mark, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, and Ostergren, Jan

Abstract

This study aims to establish the benefits of lowering cholesterol in diabetic patients with well-controlled hypertension and average/below-average cholesterol concentrations, but without established coronary disease.

Published
2005

210. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Author

Dahlöf, Björn, Sever, Peter S, Poulter, Neil R, Wedel, Hans, Beevers, D Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, Dahlöf, Björn, Sever, Peter S, Poulter, Neil R, Wedel, Hans, Beevers, D Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, and Ostergren, Jan

Abstract

The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics and beta blockers used. For a given reduction in blood pressure, some suggested that newer agents would confer advantages over diuretics and beta blockers. Our aim, therefore, was to compare the effect on non-fatal myocardial infarction and fatal CHD of combinations of atenolol with a thiazide versus amlodipine with perindopril.

Published
2005

211. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA)

Author

Poulter, Neil R, Wedel, Hans, Dahlöf, Björn, Sever, Peter S, Beevers, D Gareth, Caulfield, Mark, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, Pocock, Stuart, Poulter, Neil R, Wedel, Hans, Dahlöf, Björn, Sever, Peter S, Beevers, D Gareth, Caulfield, Mark, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, and Pocock, Stuart

Abstract

Results of the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) show significantly lower rates of coronary and stroke events in individuals allocated an amlodipine-based combination drug regimen than in those allocated an atenolol-based combination drug regimen (HR 0.86 and 0.77, respectively). Our aim was to assess to what extent these differences were due to significant differences in blood pressures and in other variables noted after randomisation.

Published
2005

212. Bariatric Surgery and Long-Term Cardiovascular Events

Author

Sjöström, Lars, primary, Peltonen, Markku, additional, Jacobson, Peter, additional, Sjöström, C. David, additional, Karason, Krisjan, additional, Wedel, Hans, additional, Ahlin, Sofie, additional, Anveden, Åsa, additional, Bengtsson, Calle, additional, Bergmark, Gerd, additional, Bouchard, Calude, additional, Carlsson, Björn, additional, Dahlgren, Sven, additional, Karlsson, Jan, additional, Lindroos, Anna-Karin, additional, Lönroth, Hans, additional, Narbro, Kristina, additional, Näslund, Ingmar, additional, Olbers, Torsten, additional, Svensson, Per-Arne, additional, and Carlsson, Lena M.S., additional

Published
2012
Full Text
View/download PDF

214. Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects

Author

Carlsson, Lena M.S., primary, Peltonen, Markku, additional, Ahlin, Sofie, additional, Anveden, Åsa, additional, Bouchard, Claude, additional, Carlsson, Björn, additional, Jacobson, Peter, additional, Lönroth, Hans, additional, Maglio, Cristina, additional, Näslund, Ingmar, additional, Pirazzi, Carlo, additional, Romeo, Stefano, additional, Sjöholm, Kajsa, additional, Sjöström, Elisabeth, additional, Wedel, Hans, additional, Svensson, Per-Arne, additional, and Sjöström, Lars, additional

Published
2012
Full Text
View/download PDF

216. The impact of birth weight on coronary heart disease morbidity and mortality in a birth cohort followed up for 85 years : a population-based study of men born in 1913

Author

Eriksson, Margaretha, Wallander, Mari-Ann, Krakau, Ingvar, Wedel, Hans, Svärdsudd, Kurt, Eriksson, Margaretha, Wallander, Mari-Ann, Krakau, Ingvar, Wedel, Hans, and Svärdsudd, Kurt

Abstract

Objectives. To analyse whether there is a relationship between birth weight on the one hand and coronary heart disease (CHD) and cardiovascular disease (CVD) mortality and morbidity on the other, whether such a relationship is influenced by potential modifying factors from the time of birth, adult height and the presence of diabetes, and what significance these possible associations might have for the CHD and CVD rates in the general population. Design. Population-based birth cohort. Setting. Sweden. Subjects. A total of 1319 singleton men born in 1913, surviving until age 20 and from then on followed until 85 years of age. Main outcome measures. CHD and CVD mortality and morbidity events. Results. The gestational age adjusted CHD and CVD mortality and morbidity hazard ratios were virtually unaffected by birth weight. Taking possible effect-modifying variables into account did not change the results. The population attributable risk percentage for CHD and CVD mortality and morbidity due to a birth weight ≤3000 g was 1% or less. Conclusions. Birth weight did not significantly affect CHD or CVD mortality or morbidity. A birth weight ≤3000 g contributes little to the burden of CHD and CVD on a community level.

Published
2004
Full Text
View/download PDF

217. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.

Author

Okin, Peter M, Devereux, Richard B, Jern, Sverker, Kjeldsen, Sverre E, Julius, Stevo, Nieminen, Markku S, Snapinn, Steven, Harris, Katherine E, Aurup, Peter, Edelman, Jonathan M, Wedel, Hans, Lindholm, Lars H, Dahlöf, Björn, Okin, Peter M, Devereux, Richard B, Jern, Sverker, Kjeldsen, Sverre E, Julius, Stevo, Nieminen, Markku S, Snapinn, Steven, Harris, Katherine E, Aurup, Peter, Edelman, Jonathan M, Wedel, Hans, Lindholm, Lars H, and Dahlöf, Björn

Published
2004

218. Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy : the LIFE study.

Author

Reims, Henrik M, Oparil, Suzanne, Kjeldsen, Sverre E, Devereux, Richard B, Julius, Stevo, Brady, William E, Fyhrquist, Frej, Ibsen, Hans, Lindholm, Lars H, Omvik, Per, Wedel, Hans, Beevers, Gareth, de Faire, Ulf, Kristianson, Krister, Lederballe-Pedersen, Ole, Nieminen, Markku S, Dahlöf, Björn, Reims, Henrik M, Oparil, Suzanne, Kjeldsen, Sverre E, Devereux, Richard B, Julius, Stevo, Brady, William E, Fyhrquist, Frej, Ibsen, Hans, Lindholm, Lars H, Omvik, Per, Wedel, Hans, Beevers, Gareth, de Faire, Ulf, Kristianson, Krister, Lederballe-Pedersen, Ole, Nieminen, Markku S, and Dahlöf, Björn

Published
2004

219. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Author

Sever, Peter S, Dahlöf, Björn, Poulter, Neil R, Wedel, Hans, Beevers, Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, Sever, Peter S, Dahlöf, Björn, Poulter, Neil R, Wedel, Hans, Beevers, Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, and Ostergren, Jan

Abstract

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventionally deemed dyslipidaemic.

Published
2004

220. Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study

Author

Dahlqvist, Sofia, Rosengren, Annika, Gudbjörnsdottir, Soffia, Pivodic, Aldina, Wedel, Hans, Kosiborod, Mikhail, Svensson, Ann-Marie, and Lind, Marcus

Abstract

Type 1 diabetes is associated with an increased risk of developing several cardiovascular complications. To our knowledge, the independent association between type 1 diabetes and atrial fibrillation has not been studied.

Published
2017
Full Text
View/download PDF

221. Glycaemic control and excess risk of major coronary events in persons with type 1 diabetes

Author

Matuleviciene-Anangen, Viktorija, Rosengren, Annika, Svensson, Ann-Marie, Pivodic, Aldina, Gudbjornsdottir, Soffia, Wedel, Hans, Kosiborod, Mikhail, Haraldsson, Borje, and Lind, Marcus

Abstract

ObjectiveThe excess risk of major coronary events (acute myocardial infarction (AMI) or death from coronary heart disease (CHD)) in individuals with type 1 diabetes (T1D) in relation to glycaemic control and renal complications is not known.MethodsIndividuals with T1D in the Swedish National Diabetes Registry after 1 January 1998, without a previous MI (n=33 170) and 1 64 698 controls matched on age, sex and county were followed with respect to non-fatal AMI or death from CHD. Data were censored at death due to any cause until 31 December 2011.ResultsDuring median follow-up of 8.3 and 8.9 years for individuals with T1D and controls, respectively, 1500 (4.5%) and 1925 (1.2%), experienced non-fatal AMI or died from CHD, adjusted HR 4.07 (95% CI 3.79 to 4.36). This excess risk increased with younger age, female sex, worse glycaemic control and severity of renal complications.The adjusted HR in men with T1D with updated mean haemoglobin A1c (HbA1c) <6.9% (52 mmol/mol) and normoalbuminuria was 1.30 (95% CI 0.90 to 1.88) and in women 3.16 (95% CI 2.14 to 4.65). HRs increased to 10.7 (95% CI 8.0 to 14.3) and 31.8 (95% CI 23.6 to 42.8) in men and women, respectively, with HbA1c >9.7% and renal complications.ConclusionsThe excess risk of AMI in T1D is substantially lower with good glycaemic control, absence of renal complications and men compared with women. In women, the excess risk of AMI or CHD death persists even among patients with good glycaemic control and no renal complications.

Published
2017
Full Text
View/download PDF

226. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Author

Sever, Peter S, Dahlöf, Björn, Poulter, Neil R, Wedel, Hans, Beevers, Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, Ostergren, Jan, Sever, Peter S, Dahlöf, Björn, Poulter, Neil R, Wedel, Hans, Beevers, Gareth, Caulfield, Mark, Collins, Rory, Kjeldsen, Sverre E, Kristinsson, Arni, McInnes, Gordon T, Mehlsen, Jesper, Nieminen, Markku, O'Brien, Eoin, and Ostergren, Jan

Abstract

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol lowering in the primary prevention of coronary heart disease (CHD) in hypertensive patients who are not conventionally deemed dyslipidaemic.

Published
2003

229. Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure

Author

McMurray, John J.V., primary, Dunselman, Peter, additional, Wedel, Hans, additional, Cleland, John G.F., additional, Lindberg, Magnus, additional, Hjalmarson, Åke, additional, Kjekshus, John, additional, Waagstein, Finn, additional, Apetrei, Eduard, additional, Barrios, Vivencio, additional, Böhm, Michael, additional, Kamenský, Gabriel, additional, Komajda, Michel, additional, Mareev, Vyacheslav, additional, and Wikstrand, John, additional

Published
2010
Full Text
View/download PDF

230. Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)

Author

McMurray, John J.V., primary, Kjekshus, John, additional, Gullestad, Lars, additional, Dunselman, Peter, additional, Hjalmarson, Åke, additional, Wedel, Hans, additional, Lindberg, Magnus, additional, Waagstein, Finn, additional, Grande, Peer, additional, Hradec, Jaromir, additional, Kamenský, Gabriel, additional, Korewicki, Jerzy, additional, Kuusi, Timo, additional, Mach, François, additional, Ranjith, Naresh, additional, and Wikstrand, John, additional

Published
2009
Full Text
View/download PDF

231. Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

Author

Cleland, John G.F., primary, McMurray, John J.V., additional, Kjekshus, John, additional, Cornel, Jan H., additional, Dunselman, Peter, additional, Fonseca, Cândida, additional, Hjalmarson, Åke, additional, Korewicki, Jerzy, additional, Lindberg, Magnus, additional, Ranjith, Naresh, additional, van Veldhuisen, Dirk J., additional, Waagstein, Finn, additional, Wedel, Hans, additional, and Wikstrand, John, additional

Published
2009
Full Text
View/download PDF

233. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial

Author

Sjöström, Lars, primary, Gummesson, Anders, additional, Sjöström, C David, additional, Narbro, Kristina, additional, Peltonen, Markku, additional, Wedel, Hans, additional, Bengtsson, Calle, additional, Bouchard, Claude, additional, Carlsson, Björn, additional, Dahlgren, Sven, additional, Jacobson, Peter, additional, Karason, Kristjan, additional, Karlsson, Jan, additional, Larsson, Bo, additional, Lindroos, Anna-Karin, additional, Lönroth, Hans, additional, Näslund, Ingmar, additional, Olbers, Torsten, additional, Stenlöf, Kaj, additional, Torgerson, Jarl, additional, and Carlsson, Lena MS, additional

Published
2009
Full Text
View/download PDF

237. The Influence of Renal Function on Clinical Outcome and Response to β-Blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)

Author

Ghali, Jalal K., primary, Wikstrand, John, additional, Van Veldhuisen, Dirk J., additional, Fagerberg, Björn, additional, Goldstein, Sidney, additional, Hjalmarson, Åke, additional, Johansson, Peter, additional, Kjekshus, John, additional, Ohlsson, Lis, additional, Samuelsson, Ola, additional, Waagstein, Finn, additional, and Wedel, Hans, additional

Published
2009
Full Text
View/download PDF

245. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study

Author

Olsen, Michael Hecht, primary, Wachtell, Kristian, additional, Beevers, Gareth, additional, Dahlöf, Björn, additional, de Simone, Giovanni, additional, Devereux, Richard B, additional, de Faire, Ulf, additional, Fyhrquist, Frej, additional, Ibsen, Hans, additional, Kjeldsen, Sverre E, additional, Lederballe-Pedersen, Ole, additional, Lindholm, Lars H, additional, Lyle, Paulette A, additional, Nieminen, Markku S, additional, Omvik, Per, additional, Oparil, Suzanne, additional, and Wedel, Hans, additional

Published
2009
Full Text
View/download PDF

248. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertension (LIFE) study

Author

Olsen, Michael Hecht, primary, Wachtell, Kristian, additional, Beevers, Gareth, additional, Dahlöf, Björn, additional, Devereux, Richard B., additional, de Faire, Ulf, additional, Fyhrquist, Frej, additional, Ibsen, Hans, additional, Kjeldsen, Sverre E., additional, Lederballe-Pedersen, Ole, additional, Lindholm, Lars H., additional, Narayan, Puneet, additional, Nieminen, Markku S., additional, Omvik, Per, additional, Oparil, Suzanne, additional, and Wedel, Hans, additional

Published
2009
Full Text
View/download PDF

249. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes

Author

Östergren, Jan, primary, Poulter, Neil R, additional, Sever, Peter S, additional, Dahlöf, Björn, additional, Wedel, Hans, additional, Beevers, Gareth, additional, Caulfield, Mark, additional, Collins, Rory, additional, Kjeldsen, Sverre E, additional, Kristinsson, Arni, additional, McInnes, Gordon T, additional, Mehlsen, Jesper, additional, Nieminen, Markku, additional, and O'Brien, Eoin, additional

Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results